Jim Cramer’s Take on 24 Stocks: Cisco, Eli Lilly, and Ford
In this article, we will look at the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up for this market.
Abbott Laboratories (ABT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Diamond Hill Capital Ric Dillon | 5,378,840 | $552,245,503 | +5% | 3.45% |
| 2. | Locust Wood Capital Advisers Stephen J. Errico | 1,077,201 | $110,596,193 | +13% | 2.82% |
| 3. | Fisher Asset Management Ken Fisher | 752,105 | $77,218,682 | -94% | 0.03% |
| 4. | Walleye Capital Will England | 406,461 | $41,731,351 | +118% | 0.17% |
| 5. | Impax Asset Management Ian Simm | 206,569 | $21,208,439 | +62% | 0.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $92.65 | 10,000 | $926,537.00 | 6,751,103 | 2026-04-27 | Filing | |
| $91.50 | 2,200 | $201,300.00 | 2,200 | 2026-04-23 | Filing | |
| $108.33 | 5,033 | $545,238.98 | 6,738,817 | 2026-02-04 | Filing | |
| $109.14 | 4,967 | $542,092.42 | 6,733,784 | 2026-02-04 | Filing | |
| $107.13 | 18,800 | $2,013,966.92 | 216,203 | 2026-01-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $115.58 | 709 | $81,946.22 | 39,164 | 2026-03-02 | Filing | |
| $115.58 | 885 | $102,288.30 | 146,377 | 2026-03-02 | Filing | |
| $115.58 | 1,144 | $132,223.52 | 76,843 | 2026-03-02 | Filing | |
| $115.58 | 613 | $70,850.54 | 104,291 | 2026-03-02 | Filing | |
| $115.58 | 585 | $67,614.30 | 24,628 | 2026-03-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 112,949,933 | $11,596,569,621 | 0.29% | |
| 2. | 47,944,891 | $4,922,501,959 | 0.26% | |
| 3. | 15,909,341 | $1,633,412,009 | 0.31% | |
| 4. | 14,091,704 | $1,446,795,249 | 0.48% | |
| 5. | 12,442,717 | $1,277,493,781 | 0.23% |
News See All
Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 Software
Abbott Laboratories (NYSE:ABT) is one of the best medical device stocks to invest in right now. Abbott Laboratories (NYSE:ABT) announced on April 28 that it received the U.S.
Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
10 Best Medical Device Stocks to Invest In Right Now
On April 27, Tom Lee, Fundstrat Capital Chief Investment Officer and Bitmine Immersion Technologies Chairman, appeared on CNBC's ‘Power Lunch’ to discuss the outlook for equity markets.
10 Best Bear Market Stocks to Invest In Right Now
A stock index is considered to be in a bear market when its closing price falls at least 20% from its most recent high. A correction is milder, with losses between 10% and 19.9%.
Abbott Laboratories (NYSE:ABT) Q1 2026 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to Abbott Laboratories' First Quarter 2026 Earnings Conference Call.
12 Oversold Blue Chip Stocks to Buy According to Analysts
Oversold blue chip stocks are drawing a closer look, but not just because they have fallen.
Jim Cramer's Game Plan for 12 Stocks and His Take on the Market Post Iran-U.S. Ceasefire Talks
In this article, we will look at the stocks on Jim Cramer’s game plan as he shared his take on the market post-Iran-U.S. ceasefire talks.
15 Best Consistent Dividend Stocks to Buy Right Now
According to an April 6 report by CNBC, if the Iran war drags on longer than expected, investors may want to look at defensive stocks that pay dividends, according to Jefferies.
Conservative Stock Portfolio: 7 Best Stocks to Buy Right Now
On March 24, Reuters reported that Barclays raised its 2026 year-end S&P 500 target on the heels of robust corporate earnings, thanks to the broader technology sector and resilience in economic growth...
Hedge Fund Resource Center